title: Glucantime fever with parenteral meglumine antimonate in patients of cutaneous leishmaniasis.
authors.forename: Brigadier Nasser
authors.initials: BN
authors.lastname: Rashid
authors.forename: Sadia
authors.initials: S
authors.lastname: Tabassum
authors.forename: Major Sibghat
authors.initials: MS
authors.lastname: Ullah Rao
authors.forename: Sadia
authors.initials: S
authors.lastname: Masood
authors.forename: Major Muhammad
authors.initials: MM
authors.lastname: Abbas
authors.forename: Major Jauhar
authors.initials: MJ
authors.lastname: Mumtaz
mesh_terms: D000965:Antimony / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D008536:Meglumine / Q000009:adverse effects* / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony